P.A.W. Capital’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-8,333
| Closed | -$295K | – | 26 |
|
|
2022
Q4 | $295K | Sell |
8,333
-9,667
| -54% | -$342K | 0.81% | 23 |
|
|
2022
Q3 | $4.07M | Hold |
18,000
| – | – | 6.09% | 2 |
|
|
2022
Q2 | $3.4M | Hold |
18,000
| – | – | 4.94% | 5 |
|
|
2022
Q1 | $4.48M | Buy |
18,000
+1,333
| +8% | +$332K | 4.68% | 5 |
|
|
2021
Q4 | $2.6M | Buy |
16,667
+3,334
| +25% | +$519K | 2.38% | 14 |
|
|
2021
Q3 | $2.67M | Hold |
13,333
| – | – | 2.38% | 12 |
|
|
2021
Q2 | $3.41M | Buy |
13,333
+666
| +5% | +$170K | 2.86% | 11 |
|
|
2021
Q1 | $3.36M | Sell |
12,667
-666
| -5% | -$177K | 2.96% | 11 |
|
|
2020
Q4 | $4.92M | Buy |
13,333
+1,333
| +11% | +$491K | 4.34% | 6 |
|
|
2020
Q3 | $2.93M | Buy |
12,000
+2,000
| +20% | +$488K | 3.19% | 13 |
|
|
2020
Q2 | $2.88M | Sell |
10,000
-2,000
| -17% | -$576K | 3.26% | 11 |
|
|
2020
Q1 | $2.45M | Buy |
12,000
+7,200
| +150% | +$1.47M | 3.3% | 11 |
|
|
2019
Q4 | $2.15M | Sell |
4,800
-1,867
| -28% | -$835K | 2.29% | 19 |
|
|
2019
Q3 | $2.05M | Hold |
6,667
| – | – | 2.56% | 14 |
|
|
2019
Q2 | $2.12M | Buy |
6,667
+334
| +5% | +$106K | 2.29% | 17 |
|
|
2019
Q1 | $2.66M | Sell |
6,333
-1,000
| -14% | -$419K | 2.63% | 10 |
|
|
2018
Q4 | $2.24M | Buy |
7,333
+6,166
| +528% | +$1.88M | 2.8% | 12 |
|
|
2018
Q3 | $420K | Sell |
1,167
-1,833
| -61% | -$660K | 0.45% | 59 |
|
|
2018
Q2 | $1.1M | Sell |
3,000
-1,500
| -33% | -$549K | 1.11% | 28 |
|
|
2018
Q1 | $1.33M | Buy |
4,500
+1,167
| +35% | +$345K | 1.6% | 23 |
|
|
2017
Q4 | $1.4M | Buy |
3,333
+666
| +25% | +$279K | 1.75% | 21 |
|
|
2017
Q3 | $880K | Buy |
+2,667
| New | +$880K | 0.92% | 48 |
|